Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Active Not Recruiting Phase 2 Trials for Tacrolimus (DB00864)

IndicationStatusPhase
DBCOND0029923 (Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01858740Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in ChildrenTreatment